-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, EIqU2cceM0qV45hpTfYsCZneHGEx2gbMZgj5hVsb/N4lEIXTPOTItzpZxIbvEq1S 4JImfpClfRIls9iiRxPnfQ== 0000897446-94-000035.txt : 19940620 0000897446-94-000035.hdr.sgml : 19940620 ACCESSION NUMBER: 0000897446-94-000035 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19940617 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBIA HCA HEALTHCARE CORP/ CENTRAL INDEX KEY: 0000860730 STANDARD INDUSTRIAL CLASSIFICATION: 8062 IRS NUMBER: 752497104 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-41652 FILM NUMBER: 94534799 BUSINESS ADDRESS: STREET 1: 201 WEST MAIN STREET CITY: LOUISVILLE STATE: KY ZIP: 40202- BUSINESS PHONE: (502)-572-2000 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA HEALTHCARE CORP DATE OF NAME CHANGE: 19930830 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA HOSPITAL CORP DATE OF NAME CHANGE: 19930328 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RECANATI RAPHAEL CENTRAL INDEX KEY: 0000919521 STANDARD INDUSTRIAL CLASSIFICATION: 0000 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: 511 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125781857 SC 13D 1 SCHEDULE 13 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Columbia/HCA Healthcare Corporation (formerly Columbia Healthcare Corporation) (Name of Issuer) Common Stock, $.01 par value per share (Title of Class of Securities) 197677 10 7 (CUSIP Number) Carolyn L. Monroe-Koatz, J.P. Morgan & Co. Incorporated, 60 Wall Street, New York, New York 10260 (212) 648-3406 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 15, 1994 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1 (b)(3) or (4), check the following box. Check the following box if a fee is being paid with the statement. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 3 Pages Pursuant to Rule 13d-2(a) of Regulation 13D-G of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended, the undersigned hereby amend Item 5 of their Schedule 13D statement dated February 22, 1994 relating to the Common Stock, par value $.01 per share (the "Common Stock"), of Columbia/HCA Healthcare Corporation ("Columbia/HCA"), a Delaware corporation with principal executive offices at 201 West Main Street, Louisville, Kentucky 40202. Unless otherwise indicated, all defined terms used herein shall have the same meanings as those set forth in the Schedule 13D. On June 15, 1994 (the "Closing"), JPMCC sold 6,900,000 shares of Common Stock in an underwritten public offering pursuant to an underwriting agreement (the "Underwriting Agreement") dated June 8, 1994 among Columbia/HCA, JPMCC and the underwriters named therein (the "Underwriters"). At the Closing, JPMCC converted 4,800,000 shares of Nonvoting Common Stock into 4,800,000 shares of Common Stock and, pursuant to the Underwriting Agreement, immediately thereafter sold and transferred a total of 6,900,000 shares of Common Stock to the Underwriters for the aggregate price of $271,066,500. As a result of the sale and transfer of such shares by JPMCC to the Underwriters, the Reporting Persons own, in the aggregate, less than 5% of the Common Stock of Columbia/HCA. Signature After reasonable inquiry and to the best of each of the undersigned's knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: June 17, 1994 J.P. MORGAN & CO. INCORPORATED By: /s/ James C.P. Berry Name: James C.P. Berry Title: Vice President and Assistant General Counsel J.P. MORGAN HOLDINGS INC. By: /s/ James C.P. Berry Name: James C.P. Berry Title: Secretary J.P. MORGAN CAPITAL CORPORATION By: /s/ David M. Cromwell Name: David M. Cromwell Title: Director -----END PRIVACY-ENHANCED MESSAGE-----